GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sisram Medical Ltd (OTCPK:SRAMF) » Definitions » COGS-to-Revenue

Sisram Medical (Sisram Medical) COGS-to-Revenue : 0.39 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Sisram Medical COGS-to-Revenue?

Sisram Medical's Cost of Goods Sold for the six months ended in Dec. 2023 was $73.4 Mil. Its Revenue for the six months ended in Dec. 2023 was $187.7 Mil.

Sisram Medical's COGS to Revenue for the six months ended in Dec. 2023 was 0.39.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sisram Medical's Gross Margin % for the six months ended in Dec. 2023 was 60.87%.


Sisram Medical COGS-to-Revenue Historical Data

The historical data trend for Sisram Medical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sisram Medical COGS-to-Revenue Chart

Sisram Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.45 0.44 0.43 0.43 0.39

Sisram Medical Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.43 0.43 0.39 0.39

Sisram Medical COGS-to-Revenue Calculation

Sisram Medical's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=139.767 / 359.292
=0.39

Sisram Medical's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=73.444 / 187.671
=0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sisram Medical  (OTCPK:SRAMF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sisram Medical's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 73.444 / 187.671
=60.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Sisram Medical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sisram Medical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sisram Medical (Sisram Medical) Business Description

Traded in Other Exchanges
Address
HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.

Sisram Medical (Sisram Medical) Headlines

No Headlines